Skip to main content

Krogulski Kenneth's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Aug 13, 2021

Accession no.
0001209191-21-051443
Filed
Aug 13, 2021
Trade date
Jul 1-30, 2021
Filing delay
43 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $5.83K. It was filed 43 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krogulski KennethCIK 0001695580Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 1, 2021Common StockPPurchaseAcquired+85$2.91+$247.35172,085Direct
Jul 2, 2021Common StockPPurchaseAcquired+85$2.94+$249.9172,170Direct
Jul 6, 2021Common StockPPurchaseAcquired+85$3.14+$266.9172,255Direct
Jul 7, 2021Common StockPPurchaseAcquired+85$3.19+$271.15172,340Direct
Jul 8, 2021Common StockPPurchaseAcquired+85$3.18+$270.3172,425Direct
Jul 9, 2021Common StockPPurchaseAcquired+85$3.13+$266.05172,510Direct
Jul 12, 2021Common StockPPurchaseAcquired+85$3.33+$283.05172,595Direct
Jul 13, 2021Common StockPPurchaseAcquired+85$3.48+$295.8172,680Direct
Jul 14, 2021Common StockPPurchaseAcquired+85$3.33+$283.05172,765Direct
Jul 15, 2021Common StockPPurchaseAcquired+85$3.27+$277.95172,850Direct
Jul 16, 2021Common StockPPurchaseAcquired+85$3.28+$278.8172,935Direct
Jul 19, 2021Common StockPPurchaseAcquired+85$3.23+$274.55173,020Direct
Jul 20, 2021Common StockPPurchaseAcquired+85$3.24+$275.4173,105Direct
Jul 21, 2021Common StockPPurchaseAcquired+85$3.26+$277.1173,190Direct
Jul 22, 2021Common StockPPurchaseAcquired+85$3.36+$285.6173,275Direct
Jul 23, 2021Common StockPPurchaseAcquired+85$3.35+$284.75173,360Direct
Jul 26, 2021Common StockPPurchaseAcquired+85$3.39+$288.15173,445Direct
Jul 27, 2021Common StockPPurchaseAcquired+85$3.39+$288.15173,530Direct
Jul 28, 2021Common StockPPurchaseAcquired+85$3.42+$290.7173,615Direct
Jul 29, 2021Common StockPPurchaseAcquired+85$3.42+$290.7173,700Direct
Jul 30, 2021Common StockPPurchaseAcquired+85$3.31+$281.35173,785Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)